An international clinical trial shows an innovative CAR-T cell immunotherapy is promising against aggressive T cell cancers and has manageable side effects.

More than $300 million in grant money promised to UCI, UCLA, USC and dozens of other California institutions has been axed ...

An online platform may help increase access to and reduce barriers associated with germline testing for individuals with cancer, according to findings presented at ASCO Annual Meeting.An analysis of ...

There is a mystical aspect about teddy bears in that they provide unconditional love. They are symbols of love. When a cancer ...

UC researchers have found how the MYC oncogene fuels lymphoma by altering cell metabolism, paving the way for targeted ...

Cancer remains one of the biggest health challenges of our lifetime. Millions of people globally receive a cancer diagnosis each year — in the United States, that’s about one diagnosis every 30 ...

When cancer is in the lungs, the simulation reveals patients can die from asphyxiation, where there's not enough oxygen ...

The company's flagship assay uses whole-genome sequencing to identify patients with high-risk multiple myeloma and determine which patients won't respond to therapies.

Metabolic reprogramming is now recognized as a hallmark of cancer, playing a pivotal role in tumor progression, therapeutic resistance, immune evasion, and ...

A proposed $21 million cancer center at Southwestern Vermont Medical Center could be close to receiving permitting approval ...

After a multi-year process of development and garnering approvals, the new Genetic Counseling Graduate Program at UB has received accreditation from the Accreditation Council for Genetic Counseling ...

A new avenue for targeted drug delivery has been proposed by researchers from The Grainger College of Engineering at the ...